Načítá se...
The Mibefradil Derivative NNC55-0396, a Specific T-Type Calcium Channel Antagonist, Exhibits Less CYP3A4 Inhibition than Mibefradil
A novel mibefradil derivative, NNC55-0396, designed to be hydrolysis resistant was shown to be a selective T-type Ca(2+) channel inhibitor without L-type Ca(2+) channel efficacy. However, its effects on cytochrome P450s have not previously been examined. We investigated the inhibitory effects of NNC...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2927974/ https://ncbi.nlm.nih.gov/pubmed/18411403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.107.020115 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|